ArticleTranslational pediatrics2026
Clinical characteristics and mutation analysis of Chinese children with 17α-hydroxylase deficiency: a report on three cases.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: 17α-hydroxylase deficiency (17-OHD) is an uncommon type of congenital adrenal hyperplasia. It manifests as hypokalemia, hypertension, and hypergonadotropic hypogonadism and arises from a mutation in the Case Description: The patients in this case report were admitted to hospital for unusual growth velocity. Examinations revealed that their actual bone age was younger than their chronological age. However, their height was greater than the height predicted according to their bone age. This was speculated to be due to a lack of estrogen and subsequent delayed epiphyseal closure. Despite the delay in growth, it was determined that the patients would eventually grow to an above average, tall stature. Pelvic ultrasound or magnetic resonance imaging (MRI) revealed the absence of gonads in a patient with the 46,XY karyotype. Gene testing confirmed a novel variant and three reported variants in the Conclusions: For patients with an unusual growth velocity, absence of secondary sexual characteristics, hypertension, and hypokalemia, laboratory data, karyotyping, pelvic ultrasound or MRI, and bone age can be useful in arriving at a diagnosis of 17-OHD in a timely manner, with gene testing being recommended to confirm the diagnosis. An unusual growth velocity, with the actual height greater than that predicted by bone age, may be a useful indicator of 17-OHD, especially when it is difficult for clinical physicians to perform gene testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.